Skip to main content

MoneyWorks4Me

Procter&Gamble Healt - Quaterly Results

03 Nov 2026 Evaluate
The revenue zoomed 17.72% to Rs. 3824.90 millions for the quarter ended September 2026 as compared to Rs. 3249.20 millions during the corresponding quarter last year.A comparatively good net profit growth of 25.94% to Rs. 1115.10 millions was reported for the quarter ended September 2026 compared to Rs. 885.40 millions of previous same quarter.OP of the company witnessed a marginal growth to 1562.60 millions from 1252.20 millions in the same quarter last year.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 3824.90 3249.20 17.72 7462.00 6636.60 12.44 14079.70 0.00 0.00
Other Income 38.90 49.50 -21.41 77.70 89.80 -13.47 173.40 0.00 0.00
PBIDT 1562.60 1252.20 24.79 2597.40 2195.90 18.28 4740.00 0.00 0.00
Interest 1.30 1.20 8.33 2.70 2.40 12.50 5.50 0.00 0.00
PBDT 1561.30 1251.00 24.80 2912.70 2193.50 32.79 4734.50 0.00 0.00
Depreciation 60.80 60.80 0.00 121.00 115.20 5.03 235.90 0.00 0.00
PBT 1500.50 1190.20 26.07 2791.70 2078.30 34.33 4498.60 0.00 0.00
TAX 385.40 304.80 26.44 715.10 531.10 34.65 1229.50 0.00 0.00
Deferred Tax 25.90 -0.60 -4416.67 45.30 -3.70 -1324.32 44.60 0.00 0.00
PAT 1115.10 885.40 25.94 2076.60 1547.20 34.22 3269.10 0.00 0.00
Equity 166.00 166.00 0.00 166.00 166.00 0.00 166.00 0.00 0.00
PBIDTM(%) 40.85 38.54 6.01 34.81 33.09 5.20 33.67 0.00 0.00
Peers
Company Name CMP
Sun Pharma. Inds. 1771.95
Dr. Reddys Labs. 1370.00
Cipla 1392.20
Lupin 2012.00
Zydus Lifesciences 1239.00
View more..